Hester Biosciences peers

Companies like Hester Bioscienceslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HESTERBIO₹2,243.70

Hester Biosciences Limited

· Pharma & Health
₹ CrorePeersWINDLASSYNCOMFNGLFINEINDOCOSAIPARENTJAGSNPHARMPANACEABIOMcap ₹1,909 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
HESTERBIO
FY26
WINDLAS
FY26
SYNCOMF
FY26
NGLFINE
FY26
Peer
Average
Valuation — at last close
P/E33.21×28.12×◆ 25.10×33.51×28.91× +15%
P/B5.30×◆ 3.23×4.61×4.90×4.25× +25%
EV/EBITDA24.21×◆ 15.61×23.24×23.07×20.64× +17%
Market Cap₹1,909 Cr₹1,876 Cr₹1,911 Cr₹1,613 Cr₹1,800 Cr +6%
Growth
Revenue CAGR 3Y7.72%20.78%◆ 29.69%21.68%24.05% -68%
Revenue CAGR 5Y9.19%————
Net Income CAGR 3Y27.04%15.95%◆ 56.16%32.91%35.01% -23%
Revenue YoY (latest Q)-8.16%17.66%7.38%◆ 33.57%19.54% -142%
Net Income YoY (latest Q)◆ 459.27%-1.79%57.71%99.09%51.67% +789%
Profitability
EBITDA Margin◆ 26.05%11.59%15.83%14.51%13.98% +86%
Net Income Margin◆ 17.28%7.35%15.63%9.61%10.86% +59%
Return on Common Equity16.50%12.23%◆ 20.19%15.74%16.05% +3%
Return on Capital Employed12.87%13.49%◆ 18.08%14.96%15.51% -17%
Return on Assets8.64%7.97%◆ 16.14%9.83%11.31% -24%
Credit & Quality
Total Debt/Equity0.51×0.05×◆ 0.00×0.33×0.13× +303%
Interest Coverage6.20×15.33×◆ 61.38×11.89×29.53× -79%
Scale — latest FY
Revenue / Total Income₹333 Cr₹904 Cr₹489 Cr₹501 Cr₹631 Cr -47%
Net Income₹57.5 Cr₹66.5 Cr₹76.4 Cr₹48.1 Cr₹63.7 Cr -10%
Total Assets₹678 Cr₹907 Cr₹534 Cr₹545 Cr₹662 Cr +2%
EPS₹67.57₹31.6₹0.81₹77.9₹36.77 +84%
Book Value per Share₹423.46₹275.2₹4.41₹532.91₹270.84 +56%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.